• About us
    • About us
    • Contact
  • Horizon Europe
  • R&I News
    • What’s new in Korea
    • What’s new in Europe
    • EU Weekly Brief
  • Activities
    • News & Activities
    • Publication
    • KERC Supporters
    • EU Research Career
  • KE-QSTCC
  • About us
    • About us
    • Contact
  • Horizon Europe
  • R&I News
    • What’s new in Korea
    • What’s new in Europe
    • EU Weekly Brief
  • Activities
    • News & Activities
    • Publication
    • KERC Supporters
    • EU Research Career
  • KE-QSTCC

Archives

vaccine

Korea’s 1st homegrown COVID-19 vaccine maker underlines global partnership

With SKYCovione, SK Bioscience CEO pins hopes on introducing Korean biotechnology to global market As SK

Read More »
October 4, 2022

Korea ‘strong match with goals of Gates Foundation,’ Bill Gates tells Yoon Suk-yeol

Bill Gates on Tuesday(16 Aug) said he hoped South Korea would take on a larger role

Read More »
August 17, 2022

SK Bioscience eyes Europe as market for COVID-19 vaccine

Global COVID-19 vaccine market expected to reach $85b in 2022: report SK Bioscience has submitted the

Read More »
August 2, 2022
EU Research Trends

코로나19 관련 R&D 현황 (7월 26일자)

코로나19 대응 연구개발 현황 (7월 26일자) 독일, 오미크론 변이체에 대한 제한된 항체 반응 연구 영국의 대규모

Read More »
July 27, 2022

S. Korea approves use of 1st homegrown COVID-19 vaccine from SK Bioscience

South Korea on Wednesday(29 Jun) approved the use of SKYCovione, the country’s first homegrown COVID-19 vaccine

Read More »
June 29, 2022

Korea close to authorizing 1st homemade vaccine

Authorities aiming to announce official approval of SK Bioscience’s SKYCovione before end of week South Korea’s

Read More »
June 28, 2022

Table of Contents

Subscribe to our weekly newsletters!

Keep up to date with R&I trends in Europe and Korea

© 2023 KERC. All Rights Reserved / Tous droits réservés / Alle rechten voorbehouden.

Developed by Yale SONG